Cholinergic and adrenergic inhibition in the rat cerebral cortex.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects*; D002794:Choline / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D008688:Methacholine Compounds / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D012677:Sensation; D012879:Skin Physiological Phenomena; D013390:Succinylcholine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology
D001565:Benzoates; D006584:Hexamethonium Compounds; D008688:Methacholine Compounds; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D009538:Nicotine; D001285:Atropine; D002217:Carbachol; D010830:Physostigmine; D013390:Succinylcholine; D002794:Choline; D000109:Acetylcholine; D014403:Tubocurarine; D009638:Norepinephrine